top of page
Winner of

Computerworld Honors 2009 

A European multidisciplinary network for the fight against HIV drug resistance


EuResist Network is an international non-profit partnership devoted to understanding and fighting the resistance to anti-HIV drugs.

Its approach is eminentely multidisciplinary and focused on exploiting the power of real world data at the benefit of the individual patient...

The EuResist Integrated Database
with data of more than 105.000 HIV patients is open for research studies.

A new article about the EuCARE schools study was just published online by the national Italian newspaper "Il fatto quotidiano".

Sara Gandini (from the European Institute of Oncology) and Francesca Incardona (EuCARE project coordinator), discuss the study's findings on the effects of distance learning on students.

The preliminary results of the EuCARE research suggest that students experienced higher anxiety, stress, and loneliness during remote learning.

This initial findings were presented at the ICAR (International Conference on Antiviral Research) in Rome in June 2024 .


EuCARE article on the distance learning and the impact on students grades and confidence

9 July 2024 

EuResist at “La sanità che vorrei”, Italian Ministry of Health

3 July 2024 

Francesca Incardona, participated in the high level institutional event on “The healthcare I wish (La sanità che vorrei)”, organized by the Italian Society for Infectious and Tropical Diseases (SIMIT).
The event is hosted by the Italian Ministry of Health in Rome on July 3 from 10:30 to 13:00 and discussed the clinical and social aspects of health education and awareness of behaviours.
Key public policy stakeholders and scientists participated in the meeting.


The EuCARE session at ICAR 2024

3 July 2024 

EuCARE presented its most recent scientific results in a dedicated session at the ICAR 2024 conference in Rome.
The session, chaired by Giulia Carla Marchetti and Francesca Ceccherini Silberstein, featured 7 presentations  from EuCARE project partners, including Maurizio Zazzi, Sara Gandini, Francesca Incardona, Elham Shamshara, Alessandro Cozzi-Lepri, Roberta Rovito e Andrea Santoro. 
The EuCARE session prompted a lively discussion with the audience in an interesting, useful Q&A session as in the spirit of ICAR.
The ICAR conference is the major Italian event in the field of HIV/AIDS research, now at its 16th edition. 


New EuResist paper on Bioinformatics

22 May 2024 

The EuResist Network is proud to announce the publication of a new EuResist paper on Bioinformatics. 
A key question in predicting HIV therapy outcomes is whether incorporating historical information can improve predictions compared to relying solely on current or most recent data. 
The paper, titled “Incorporating temporal dynamics of mutations to enhance the prediction capability of antiretroviral therapy’s outcome for HIV-1”, investigates if including past knowledge – specifically viral mutations from all pre-therapy genotypic tests, their order of detection and corresponding viral load measurements – can enhance the accuracy of predicting treatment success.

The study, led by Giulia Di Teodoro, leveraged the EuResist Integrated DataBase (EIDB). For enhanced replicability, we encourage reproducing this study with the latest EIDB release. Access is available upon contacting the EuResist Network.

A new phase of the KRG-HIS Project

May 2024 

A very important milestone for the KRG-HIS Project achieved in Kurdistan with the signature of the Memorandum of Understanding between University of Tor Vergata and the Ministry of Health of Kurdistan. 
The new phase of the KRG-HIS Project started with the visit of Tor Vergata University and EuResist representatives to the Kurdish Health Directorates with a two years plan for the complete integration of the system in the Health administration of the Region.


EuCARE data at ICAR 2024

20 June 2024 

We are delighted and honoured to have a symposium dedicated to the EuCARE project during ICAR 2024, the Italian Conference on Aids and Antiviral Research taking place in Rome from 19 to 21 June 2024.

SARS-COV-2 and its continuous evolution still pose scientific questions and challenges, including those related to its immune pathogenesis and to long-COVID. The pandemic also highlighted the need for research on areas like vaccine hesitancy and non-pharmacological interventions, e.g. in school. Thanks to a large international collaboration, the EuCARE project is trying to provide advances in a wide variety of SARS-COV-2 variants related topics. 


The symposium on Covid-19 and post-Covid conditions in 2024: data from the EuCARE project will be held on June 20th from 15:25 to 17:30.


AVITHRAPID project kickoff!

13-14 February 2024 

On 13 and 14 February in Rome, at the National Institute of Infectious Diseases, it was held the kickoff meeting of the AVITHRAPID project devoted to search and validation of broad spectrum "Antiviral Therapeutics for Rapid Response Against Pandemic Infectious Diseases".


EuResist is proudly partner of the project, in charge of the data management of the Project's clinical trials.


New EuCARE publication in the Lancet Regional Health- Europe

06 February 2024 

The reduced mortality from COVID-19 is not necessarily due to lower severity of latest variants, such as Omicron and its sub-variants.
Rather, the reduced mortality seems to be due to other factors, such as immunity from previous vaccinations and previous infections. 
This is among the outcomes of the study "Twenty-Eight-Day In-Hospital Mortality During the Wild-type, Alpha, Delta, and Omicron SARS-CoV-2 Waves: A Multinational Cohort Study in the EuCARE Project" published in the latest issue of The Lancet Regional Health Europe.
The study, which analyses data from 38,585 adult patients from the EuCARE Hospitalised cohort, comprising 10 centres across Europe, Kenya and Mexico, also highlighted that age is an important effect measure modifier regarding the association between variant and in-hospital mortality, highlighting the importance of performing age-stratified analyses, also by variant. 


From the left: A. Sönnerborg (KI), P. Naucler (KI), P. Herdberg (1st author),

A. Cozzi-Lepri (UCL)

The EuCARE Project in Il Sole 24 Ore

20 December 2023

EuCARE and the issue of preparedness on Il Sole 24 Ore, Italy's leading business daily newspaper.

The activities and results achieved after two years of the extensive work done by the whole consortium presented with a special focus placed on the importance of lessons learned in terms of preparedness in the event of a forthcoming pandemic.

In this sense, EuCARE has already collected significant data to be able to guide public stakeholders in adopting truly effective measures that, at the same time, minimise the social and psychological impacts on citizens.
You can find the article in the edition of Il Sole 24 Ore on newsstands on 20 December 2023.


On the World AIDS Day Eurosurveillance publishes a paper from the EuResist Network

1 December 2023

On the World AIDS Day, Eurosurveillance publishes a paper from the EuResist Network, originated within the CARE transnational project.

The paper’s key messages for public health are strong and timely, as war and related people displacement can rapidly change the HIV epidemics:

  • It is important to perform HIV sequence analysis to observe the spread of new subtypes.

  • People originating from Ukraine should be encouraged to be tested for HIV.

  • The high percentage of individuals infected with subtype HIV-1A6 should be taken into account when considering therapy with long-acting injectable HIV medication.


Joint Dialogue on Preparedness

24 October 2023

Are we better prepared for pandemics now? Can the problems we encountered in our experiences with COVID-19 be used to prepare better responses in the future?


Leading experts from EuCARE, RECODID, VAXTRUST, AVITHRAPID projects and from high level insititutions such as WHO, National pandemic coordination centres and top ranking universities and research centres led an interdisciplinary, interactive dialogue and discussed these themes in the Joint Dialogue on Preparedness, organised by EuCARE!


EuCARE Annual Meeting in Lisbon

23-24 October 2023

The EuCARE annual meeting was successfully held on 23th  and 24th October 2023, hosted by the Instituto de Higiene e Medicina Tropical - Universidade NOVA de Lisboa, in the presence of our distinguished Scientific and Ethics external Boards.

The very committed and proactive EuCARE partners, arrived in Portugal from all over Europe and even from Brazil, spent the two days of the meeting exchanging ideas on new studies and strategies with a special focus on how to be prepared to face a possible next pandemic. 

Thank you all, it is always a great opportunity to meet in person and thus make the meeting even more productive!


Data privacy workshop at Fondation Brocher

19-20 June 2023

The EuCARE workshop: Data privacy, data property, and data sharing: an interdisciplinary dialogue for post-pandemic transnational research was successfully held on 19th  and 20th June 2023 at the domain of the Brocher Foundation near Geneva, Switzerland

During two days of highly engaging debate, biomedical scientists advocated for a more research friendly data regulatory environment, whilst lawyers, ethics and IT scientists highlighted the pros and cons of possible solutions, from the very latest AI research, to visionary regulatory oriented solutions looking forward to the next laws that could enhance or further weigh down GDPR. 


The first results of the EuCARE POST COVID-19 Study presented at the Italian Conference on Aids and Antiviral Research (ICAR)

The EuCARE studies on POST COVID-19 are also approaching the dissemination stage and a presentation (of the preliminary results) will be given at ICAR 2023 (Bari 14-16 June) titled: Long COVID phenotypes and association with SARS CoV-2 variants in the EUCARE-POSTCOVID study”.
A preview of the findings was given to the last "Research to policy meeting on POST-COVID condition" organised by the EU on May 31.


They talk about us

An algorithm for Africa
An Algorithm for Africa.png
EuCARE kick-off project on TV

La didattica a distanza migliora voti e fiducia negli studenti? Gli studi scientifici dicono altro. 

8 July 2024

EuCARE article published online on Il fatto quotidiano about distance learning and the impact on students grades and confidence.


EuCARE studia l'impatto del Covid-19: quali sono le migliori azioni da intraprendere in situazioni di emergenza. 

20 December 2023

EuCARE and the issue of preparedness on Il Sole 24 Ore, Italy's leading business daily newspaper.

Il Covid ha lasciato rabbia negli studenti

13 May 2023

Article published in regional newspaper on the preliminary results of the EuCAREschool study presented during the "WeCARE for Schools" event


Covid, al via un progetto per analizzare l’effettivo contagio nelle scuole

2 June 2022

Da settembre lo studio di EuCARE. Sotto la lente anche l'impatto psicologico delle restrizioni e l'eventuale perdita di apprendimento a esse associata.

Audible by Radio Radicale:

9 November 2021

Derrick_blog_RadioRadicale-mp1132380Derrick Blog
00:00 / 02:33

EuCARE: partito lo studio internazionale sul ruolo della scuola durante la pandemia

19 June 2022

Il Metodo Lolli già applicato in 3 istituti a Lodi e Lecce


Covid, nelle scuole italiane arriva il progetto europeo ‘Eucare’

1 June 2022

Si tratta di uno studio scientifico internazionale per adottare le migliori pratiche per tutelare tutti gli studenti in queste nuove fasi della pandemia

Audible by Rai GR Parlamento

15 May 2022

L'Italia che va_F.Incardona_InterviewRai GR Parlamento
00:00 / 06:25

Coordinated by Euresist Network, 25 primary universities, hospitals and ICT research centres are collaborating to provide robust, data driven evidence to deal with SARS-CoV-2 variants and COVID-19 epidemics. 

How do SARS-COV-2 variants, coupled with other factors, influence the clinical course of COVID-19? Is there any vaccine or test escape related to variants? Do variants influence, and how, the spread in the school setting? Can we define a better testing and containment strategy  in the school setting? What is the impact of containment measures, including schools closure, on pupils and teachers?

With the support of strong immuno-virological and artificial intelligence components, the study will take advantage of large hospital patients, vaccinated healthcare workers and schools’ cohorts in Europe, Kenya, Mexico, Russia and Vietnam to find an answer to urgent issues related to science and society....



​CARE (Common Action against HIV/TB/HCV across the Regions of Europe) aims at analysing and addressing the human immunodeficiency virus (HIV), tuberculosis (TB) and hepatitis C (HCV) epidemics across Europe and Russia, by establishing new networks and consolidating previous cooperative actions between the European Union and the Russian Federation. 


Logo_JPG-1 copia.jpg

The MDR project (HIV multidrug resistance pathways in the EuResist Integrated DataBase) aims at estimating the prevalence and trend over time of MDR (multidrug resistance) in HIV patients, using descriptive statistics, retaining high value because of the large sample size and wide representativeness of the EIDB.

​​​The INTEGRATE project aims at building and maintaining a large, curated collection of virological and clinical data to increase scientific knowledge on resistance to integrase strand transfer inhibitors (InSTI) and on the most appropriate use of this class of antiretroviral agents.

EuResist Mentor School

EuResist Network organises the EuResist Mentor School (EMS) an innovative educational project finalised to train young physicians and biologists in dealing with structured data (databases). The EMS 2018 has been successfully held in Cologne 

EuResist in Africa

EuResist has been supporting partner of the EDCTP networking action: "Integrated training activities and IT infrastructures to improve capacities in eastern African area"...


EucoHIV is an independent self-constituted study group aiming at increasing scientific knowledge on HIV coreceptor usage and its clinical significance, including...


Ciao Andrea.


On Feb 4th 2019, our great friend and EuResister Andrea De Luca lost his life in a horrible car accident, at the age of 55.

One year has passed and still we miss him with incredulity and sorrow. 
Among many other projects,  Andrea joined EuResist as a key leader soon after its launch, devoting his energy, commitment and capability to the success of the Network. He was an extra lively, smart, passionate, and positive person, always ready to help and take new tasks.
His loss is a huge loss for us, for his patients, for his beloved ones, for the international research community.

Ciao Andrea, we'll always miss you.

bottom of page